READYE_LEASE
LIVE

Serial Number

79285906

Owner

MILTENYI BIOTEC B.V. & CO. KG

Attorney

Peter S. Sloane

Filing Date

Mar 24, 2020

Add to watchlist:

No watchlists yet
View on USPTO

READYE_LEASE Trademark

Serial Number: 79285906 • Registration: 6248173

READYE_LEASE is a trademark filed by MILTENYI BIOTEC B.V. & CO. KG on March 24, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

MILTENYI BIOTEC B.V. & CO. KG (38 trademarks)

BERGISCH GLADBACH 51429 , DE

Entity Type: 30

Trademark Details

Filing Date

March 24, 2020

Registration Date

January 19, 2021

Published for Opposition

November 3, 2020

Goods & Services

Chemical, biological and biochemical products, namely, antibody-dye conjugates for industrial, scientific and diagnostic purposes other than for medical use; reagents for use in separation processes for biological materials, for non-medical purposes; reagents for cell separation for non-medical purposes; cell labeling reagents for non-medical purposes; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of materials, especially of chemical and biological material, for non-medical purposes; reagents with magnetic beads for cell separation, for non-medical purposes; antibody reagents used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use other than for medical or veterinary purposes; buffer solutions and reagents for use with laboratory instruments, especially separation instruments, analysis instruments, reactors and imaging instruments, for non-medical purposes; reagents for processing of biological material, especially tissue, bone marrow, cells, blood and its components other than for medical or veterinary purposes; diagnostic reagents and preparations, in particular for separation, isolation, enrichment, depletion, detection, screening, imaging and analysis of biological material, for scientific purposes; culture media, cell culture media, freezing media, contrast agents, contrast agents for in-vivo imaging, all for scientific purposes; reagents for use in biotechnology, in biological treatment processes and in the biotechnology industry, for non-medical purposes

Scientific and technological services in the nature of analyzing biological and biochemical material and research and design services relating hereto; industrial analysis and research services, namely, cell detection and isolation; design and development of computer hardware and software for the analysis of biological and biochemical material, all of the aforementioned services for and in connection with the analysis of biological and biochemical material, especially of cellular material for biological and medical research and therapy

Pharmaceutical, medical and veterinary products as well as products for the pharmaceutical, medical and veterinary science, namely, antibody-dye conjugates for medical or veterinary purposes; reagents for medical or veterinary purposes, cell culturing media for medical or veterinary purposes, materials and ingredients for the preparation of cell culturing media for medical or veterinary purposes; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of material, especially of biological materials, reagents with magnetic beads, and antibody reagents, all for medical or veterinary purposes; buffer solutions and reagents for use with medical instruments, especially separation instruments, analysis instruments, reactor and imaging instruments all for medical or veterinary purposes; reagents for the processing of biological material, especially tissue, bone marrow, cells, blood and its components, all for medical or veterinary purposes; culture media, cell culture media, diagnostic reagents and preparations for medical and veterinary purposes; freezing media, contrast agents, contrast agents for in-vivo imaging, all for medical and veterinary purposes; pharmaceutical products, especially pharmaceutical products for the cellular therapy

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 19, 2026 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 15, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 15, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 15, 2025 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
May 16, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 22, 2021 FICS
FINAL DISPOSITION PROCESSED
Apr 21, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 19, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 19, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 3, 2020 NPUB
PUBLISHED FOR OPPOSITION
Nov 3, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 14, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 29, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 29, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 29, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 29, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 29, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 24, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 24, 2020 CRFA
ASSIGNED TO LIE
Sep 23, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 25, 2020 TROA
REFUSAL PROCESSED BY IB
Jul 24, 2020 RFNT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 14, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 14, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 14, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 14, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 14, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 14, 2020 COAR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 8, 2020 RFCS
REFUSAL PROCESSED BY MPU
Jul 8, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 8, 2020 RFCR
NON-FINAL ACTION WRITTEN
Jun 7, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Jun 2, 2020 MAFR
ASSIGNED TO EXAMINER
May 29, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 27, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 21, 2020 REPR